Business Wire

Virtuoso Surgical Robotic System Receives FDA Breakthrough Device Designation

NASHVILLE, Tenn.--(BUSINESS WIRE)--Virtuoso Surgical, Inc., a Nashville-based company developing a groundbreaking, entirely new class of robotic tools for endoscopic surgery, announced that the ...
Business Wire

Virtuoso Surgical Robotic System Used To Perform Successful First-in-Human Bladder Cancer Removal Cases: Enables Cutting Edge Surgical Approach

NASHVILLE, Tenn.--(BUSINESS WIRE)--Virtuoso Surgical Inc., a Nashville-based surgical robotics company, today announced the first-in-human use of its Virtuoso system, ushering in a new era of ...
ascopubs.org

Endoscopic balloon cryoablation against single instillation after transurethral resection of bladder cancer: A multicenter, randomized, controlled noninferiority trial.

Clinical utility of urine tumor DNA in bladder cancer patients. TheraP: 177Lu-PSMA-617 (LuPSMA) versus cabazitaxel in metastatic castration-resistant prostate cancer (mCRPC) progressing after ...
ascopubs.org

T1 G3 bladder cancer: A second-look endoscopic resection can help achieve a correct staging of a “superficial-invasive” tumor

Development and internal validation of a nomogram for prediction of prostate cancer specific survival 2, 5, 10, 15, 20 and 25 years after radical prostatectomy No significant financial relationships ...